Active	Status	Sponsor type	Region	Phase	Filter
8 Active 0 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

8 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Loseto, Giacomo
FIL_POLARDHAP, NCT05966233: R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma	Withdrawn	2	150	Europe	R-DHAP, Pola-R-DHAP	Fondazione Italiana Linfomi - ETS, Roche Pharma AG	Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B-cell Lymphoma Recurrent	01/29	01/29
FIL_CTCL, NCT06588868: Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma	Not yet recruiting	N/A	400	Europe		Fondazione Italiana Linfomi - ETS, Takeda	Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome	07/26	07/26
FIL_MOGA, NCT06113081: Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma	Recruiting	N/A	150	Europe		Fondazione Italiana Linfomi - ETS	Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome	05/25	07/25
FIL_MAB, NCT06008691: A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice	Recruiting	N/A	1500	Europe	"novel" MAB (alone or in combination)	Fondazione Italiana Linfomi - ETS, Roche Pharma AG	Non-Hodgkin Lymphoma, B-cell	10/38	10/38
Figuera, Amalia
ARISE, NCT06205498: Acalabrutinib Real World Italian obSErvational Study -	Recruiting	N/A	190	Europe	acalabrutinib, Calquence	AstraZeneca, Yghea	Chronic Lymphocytic Leukemia	02/30	02/30
NCT04627090: LCH in Adults: a Collaborative, Prospective-retrospective, Observational Study	Recruiting	N/A	186	Europe	Data collection	Gruppo Italiano Malattie EMatologiche dell'Adulto	Langerhans Cell Histiocytosis	03/24	03/24
FIL_CTCL, NCT06588868: Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma	Not yet recruiting	N/A	400	Europe		Fondazione Italiana Linfomi - ETS, Takeda	Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome	07/26	07/26
FIL_MOGA, NCT06113081: Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma	Recruiting	N/A	150	Europe		Fondazione Italiana Linfomi - ETS	Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome	05/25	07/25

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Loseto, Giacomo
FIL_POLARDHAP, NCT05966233: R-DHAP vs POLA-R-DHAP Followed by Autologous Transplant as First Salvage Treatment in Patient With Relapsed or Refractory Diffuse Large B Cell Lymphoma	Withdrawn	2	150	Europe	R-DHAP, Pola-R-DHAP	Fondazione Italiana Linfomi - ETS, Roche Pharma AG	Diffuse Large B Cell Lymphoma Refractory, Diffuse Large B-cell Lymphoma Recurrent	01/29	01/29
FIL_CTCL, NCT06588868: Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma	Not yet recruiting	N/A	400	Europe		Fondazione Italiana Linfomi - ETS, Takeda	Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome	07/26	07/26
FIL_MOGA, NCT06113081: Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma	Recruiting	N/A	150	Europe		Fondazione Italiana Linfomi - ETS	Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome	05/25	07/25
FIL_MAB, NCT06008691: A Prospective, Observational Cohort Study on the Clinical Impact of Novel Monoclonal Antibodies in B-cell Non-Hodgkin Lymphoma in Italian Clinical Practice	Recruiting	N/A	1500	Europe	"novel" MAB (alone or in combination)	Fondazione Italiana Linfomi - ETS, Roche Pharma AG	Non-Hodgkin Lymphoma, B-cell	10/38	10/38
Figuera, Amalia
ARISE, NCT06205498: Acalabrutinib Real World Italian obSErvational Study -	Recruiting	N/A	190	Europe	acalabrutinib, Calquence	AstraZeneca, Yghea	Chronic Lymphocytic Leukemia	02/30	02/30
NCT04627090: LCH in Adults: a Collaborative, Prospective-retrospective, Observational Study	Recruiting	N/A	186	Europe	Data collection	Gruppo Italiano Malattie EMatologiche dell'Adulto	Langerhans Cell Histiocytosis	03/24	03/24
FIL_CTCL, NCT06588868: Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma	Not yet recruiting	N/A	400	Europe		Fondazione Italiana Linfomi - ETS, Takeda	Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome	07/26	07/26
FIL_MOGA, NCT06113081: Real World Experience With Mogamulizumab in the Treatment of Cutaneous T-cell Lymphoma	Recruiting	N/A	150	Europe		Fondazione Italiana Linfomi - ETS	Cutaneous T Cell Lymphoma, Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Cutaneous T-Cell Lymphoma/Sezary Syndrome	05/25	07/25